To Compare The Action Of Triphala Madhu Sarpi In Computer Vision Syndrome Administered During Different Times Of The Day.

A Randomised Comparative Clinical Study of Triphala Madhu Sarpi Administered During Nishi Kala and Adhobhakata Aushadha Sevana Kala in Computer Vision Syndrome. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069361

Enrollment

Registered

2024-06-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H531- Subjective visual disturbances

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of irrespective gender & socio-economic status who spend more than 3 hours/ day in front of screen (Computer, T.V., Mobile screen). 2. Patients showing any ocular and extra ocular sign and symptoms of Computer Vision Syndrome (Red eyes, burning eyes, itching, eye strain, headache, neck/ shoulder pain/ backpain.

Exclusion criteria

Exclusion criteria: 1. Age below 10 Years and Above 40 Years. 2. Patients with clinically significant systematic disease e.g. Hypertension, Diabetes mellitus Migraine. 3. Pre-existing dry eyes or using lubricants or tear drop. 4. Patients who undergone eye surgery. 5. Patients on topical medication for long time.

Design outcomes

Primary

Measure	Time frame
Changes in the Computer Vision Syndrome– Questionnaire (CVS-Q) administered during Nishi kala and Adhobhakata aushadha sevana kala.Timepoint: 3 months duration	—

Secondary

Measure	Time frame
Difference in the Computer Vision Syndrome– Questionnaire (CVS-Q) administered during Nishi kala and Adhobhakata aushadha sevana kala.Timepoint: Patient will be assessed at baseline (0), and 3rd Months.	—

Countries

India

Contacts

Public ContactDr Sudipt Kumar Rath

National Institute of Ayurveda, Deemed to be University

sudipt@gmail.com9828376668

Outcome results